Syncrosome at the next NeuroFrance Congress in Marseille
SYNCROSOME your dedicated partner for In Vivo Efficacy Studies has been accepted for a poster presentation at NeuroFrance 2019 (Marseille, France...
17 mai, 2019 Central Nervous System
Arterial Hypertension
Pulmonary Arterial Hypertension
Myocardial Ischemia
Heart Failure
Blood loss
Parkinson’s Disease (PD)
Stroke
Brain Blood Barrier Passage
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Ulcer
Emesis & Nausea
Gastric Emptying
Intestinal Transit
Type 1 diabetes
Type 2 diabetes
Asthma
COPD
Cough
As an innovative preclinical CRO with relevant disease models we offer robust drug efficacy data and high value interpretation to assist drug discovery companies in evaluating the potential of their therapeutic compounds.
HIGH CONTENT EFFICACY DATA
PHYSIOLOGICAL BIOMARKERS
FUNCTIONAL EXPLORATION
CELLULAR, MOLECULAR AND INFLAMMATORY BIOMAKERS
IN VIVO EXPERIMENTS
RESOURCES CENTER
15
DISEASE MODELS
130
CUSTOMERS
40
TECHNICAL DATA SHEETS
Download Disease models, Technical sheets, …
Give a tour to Syncrosome Labs !
THEY TRUST US
LATEST NEWS
Syncrosome & the Translational Neuroscience Congress
As you know Syncrosome is a preclinical CRO managing efficacy in vivo/ in vitro studies with more than 15 disease models validated in house and highly...
21 janvier, 2019 Central Nervous SystemFrom all the Syncrosome Team…
We wish you Health, Happiness and Prosperity throughout the New year!! ...
03 janvier, 2019 Syncrosome News